The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 3 , Pages 713-716 , March 2010

Radiofrequency ablation for Barrett's esophagus and low-grade dysplasia in combination with an antireflux procedure: A new paradigm

Read at the Thirty-fifth Annual Meeting of The Western Thoracic Surgical Association, Banff, Alberta, Canada, June 24–27, 2009.

  • Ricardo S. dos Santos, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Boston University School of Medicine, Boston, Mass
    • Instituto Israelita de Ensino e Pesquisa Albert Einstein, São Paulo, Brazil
    • ,
  • Costas Bizekis, MD

      Affiliations

    • Department of Cardiothoracic Surgery, New York University School of Medicine, New York, NY
    • ,
  • Michael Ebright, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Boston University School of Medicine, Boston, Mass
    • ,
  • Michael DeSimone

      Affiliations

    • Department of Cardiothoracic Surgery, Boston University School of Medicine, Boston, Mass
    • ,
  • Benedict D. Daly, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Boston University School of Medicine, Boston, Mass
    • ,
  • Hiran C. Fernando, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Boston University School of Medicine, Boston, Mass
    • Corresponding Author InformationAddress for reprints: Hiran C. Fernando, MD, Boston Medical Center, 88 East Newton St, Robinson B402, Boston, MA 02118.

Received 26 June 2009 ,Revised 13 September 2009 ,Accepted 16 October 2009.

References 

  1. Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–831
  2. Sharma P, McQuaid K, Dent J, Fennerty MB, Sampliner R, Spechler S, et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology. 2004;127:310–330
  3. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology. 2002;123:461–467
  4. Shaheen N, Ransohoff DF. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. JAMA. 2002;287:1972–1981
  5. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol. 2002;97:1888–1895
  6. Falk GW. The future of endoscopic treatment of early Barrett neoplasia: the endoscopist's view. Endoscopy. 2008;40:1041–1047
  7. Sharma VK, Wang KK, Overholt BF, Lightdale CJ, Fennerty MB, Dean PJ, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc. 2007;65:185–195
  8. Hofstetter WL, Peters JH, DeMeester TR, Hagen JA, DeMeester SR, Crookes PF, et al. Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg. 2001;234:532–539
  9. O'Riordan JM, Byrne PJ, Ravi N, Keeling PW, Reynolds JV. Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery. Am J Surg. 2004;188:27–33
  10. Pouw RE, Sharma VK, Bergman JJ, Fleischer DE. Radiofrequency ablation for total Barrett's eradication: a description of the endoscopic technique, its clinical results and future prospects. Endoscopy. 2008;40:1033–1040
  11. Brandt LJ, Kauvar DR. Laser-induced transient regression of Barrett's epithelium. Gastrointest Endosc. 1992;38:619–622
  12. Berenson MM, Johnson TD, Markowitz NR, Buchi KN, Samowitz WS. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology. 1993;104:1686–1691
  13. Fernando HC, Murthy SC, Hofstetter W, Shrager JB, Bridges C, Mitchell JD, et al. The Society of Thoracic Surgeons practice guideline series: guidelines for the management of Barrett's esophagus with high-grade dysplasia. Ann Thorac Surg. 2009;87:1993–2002
  14. Prasad GA, Wang KK, Buttar NS, Wongkeesong LM, Krishnadath KK, Nichols FC, et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology. 2007;132:1226–1233
  15. Kelty CJ, Ackroyd R, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MW. Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation. Aliment Pharmacol Ther. 2004;20:1289–1296
  16. Dulai GS, Jensen DM, Cortina G, Fontana L, Ippoliti A. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc. 2005;61:232–240
  17. Sharma P, Wani S, Weston AP, Bansal A, Hall M, Mathur S, et al. A randomized controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results. Gut. 2006;55:1233–1239
  18. Gondrie JJ, Pouw RE, Sondermeijer CM, Peters FP, Curvers WL, Rosmolen WD, et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy. 2008;40:359–369
  19. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009;360:2277–2288
  20. Abbas AE, Deschamps C, Cassivi SD, Allen MS, Nichols FC, Miller DL, et al. Barrett's esophagus: the role of laparoscopic fundoplication. Ann Thorac Surg. 2004;77:393–396
  21. Berenson MM, Johnson TD, Markowitz NR, Buchi KN, Samowitz WS. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology. 1993;104:1686–1691
  22. Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst. 2008;100:1184–1187

 Disclosures: None.

PII: S0022-5223(09)01397-X

doi: 10.1016/j.jtcvs.2009.10.032

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 3 , Pages 713-716 , March 2010

Article Tools